Episodes
Ask host to enable sharing for playback control

Advancing the Treatment of ATTRv-PN: What's in the Pipeline?

4/23/2024
Guest: John Berk, MD Guest: Sami Khella, MD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:05:30

Ask host to enable sharing for playback control

ATTRv-PN: A Family Affair?

4/23/2024
Guest: John Berk, MD Guest: Noel Dasgupta, MD, FACC Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:04:29

Ask host to enable sharing for playback control

Shh…Gene-Silencing Therapies for ATTRv-PN

4/23/2024
Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:05:00

Ask host to enable sharing for playback control

Diagnosing ATTRv-PN: What's in Your Toolbox?

4/23/2024
Guest: Sami Khella, MD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:06:29

Ask host to enable sharing for playback control

Raising the Red Flag: What's Your Index of Suspicion for ATTRv-PN?

4/23/2024
Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:03:59

Ask host to enable sharing for playback control

The Multiple Faces of ATTRv-PN

4/23/2024
Guest: Sami Khella, MD Guest: Marcia Waddington-Cruz, MD, PhD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:05:00

Ask host to enable sharing for playback control

ATTRv-PN: A Complicated Disease With a Poor Prognosis

4/23/2024
Guest: John Berk, MD Guest: Sami Khella, MD Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:05:59

Ask host to enable sharing for playback control

ATTR Amyloidosis: Familial Vs Wild-Type

4/23/2024
Guest: Noel Dasgupta, MD, FACC Deepen your understanding of hereditary transthyretin amyloid polyneuropathy (ATTRv-PN) with this comprehensive CME series! Gain valuable insights from patient cases, expert lectures, and interviews. Explore the complexities of ATTRv-PN, differentiate familial vs wild-type forms, identify red flags for early detection, and review the latest diagnostic tools. Discover promising new therapies and what the future may hold for ATTRv-PN treatment. Join the experts and equip yourself to effectively manage this challenging disease and improve patient outcomes.

Duration:00:05:00

Ask host to enable sharing for playback control

Duchenne Muscular Dystrophy: Differentiating Advances in Treatment

4/15/2024
Host: Omer Abdul Hamid, MD Guest: Nancy Kuntz, MD Guest: Migvis Monduy, MD There are many unmet needs associated with the use of anti-inflammatory glucocorticoids when treating Duchenne muscular dystrophy, or DMD. These include multiple, often debilitating comorbidities that occur with long-term exposure. Join Drs. Hamid, Kuntz, and Monduy as they discuss key clinical trial data for a novel corticosteroid that may be a safer and possibly more effective option for patients with DMD than our current standard of care.

Duration:00:12:27

Ask host to enable sharing for playback control

New Frontiers in Optimizing Patient Outcomes in Multiple Sclerosis: Strategies for Early Intervention to Address Progression Independent of Relapse

3/20/2024
Host: Stephen Krieger, MD Guest: Tirisham Gyang, MD Guest: Augusto Miravalle, MD, FAAN New strategies for early intervention in multiple sclerosis (MS) are focusing on progression independent of relapse. These strategies include incorporation of high-efficacy disease modifying therapies in the early stages of MS coupled with effective management of treatment-related adverse events. Join Drs. Stephen Kreiger, Tirisham Gyang, and Augusto Miravalle for a lively, case-based exchange that will provide key ideas to take back into the clinic.

Duration:00:53:50

Ask host to enable sharing for playback control

5 Things You Need to Know About Epilepsy & Depression

2/29/2024
Host: Heidi M. Munger Clary, MD, MPH Guest: Jay Salpekar, MD, FANPA A crucial aspect of epilepsy care that often goes underappreciated is the intersection of epilepsy and depression. Join Drs. Munger Clary and Salpekar, leading experts in the field, as they raise awareness about the high prevalence of comorbid mental health disorders, particularly depression, among epilepsy patients. Together, they explore the bidirectional relationship between epilepsy and depression, emphasizing the importance of early detection and comprehensive treatment. They’ll also cover implantable therapies, specifically vagal nerve stimulation devices, as potential tools to manage both epilepsy and depression.

Duration:00:12:29

Ask host to enable sharing for playback control

Emerging Data in the Management of Acute Ischemic Stroke/TIA

2/27/2024
Host: Ashkan Shoamanesh, MD This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

Duration:00:28:59

Ask host to enable sharing for playback control

The Path Forward: What’s On the Horizon?

2/27/2024
Host: Manesh R. Patel, MD This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

Duration:00:16:59

Ask host to enable sharing for playback control

While Antiplatelets Are Good…They Aren’t for Everyone

2/27/2024
Host: Valeria Caso, MD, PhD This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

Duration:00:17:59

Ask host to enable sharing for playback control

Preventing Ischemic Stroke in Today’s World

2/27/2024
Host: Mike Sharma, MD, MSc, FRCPC This program addresses critical gaps in healthcare professionals' knowledge and practice related to the secondary prevention of a clot-related stroke in patients with an acute ischemic stroke or at high risk for TIA. By addressing these gaps and achieving the outlined learning objectives, participants will be better equipped to provide optimal patient care, ultimately improving outcomes in managing this critical medical condition.

Duration:00:15:29

Ask host to enable sharing for playback control

The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?

2/27/2024
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Greg Albers, MD Host: Rhonda Cadena, MD, FNCS, FCCM Host: Adrian R. Parry-Jones, FRCP, PhD Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

Duration:00:21:29

Ask host to enable sharing for playback control

Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient

2/27/2024
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Stuart Connolly, MD, FRCPC Host: Rhonda Cadena, MD, FNCS, FCCM Host: Greg Albers, MD Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

Duration:00:16:29

Ask host to enable sharing for playback control

ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?

2/27/2024
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Adrian R. Parry-Jones, FRCP, PhD Host: Stuart Connolly, MD, FRCPC Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

Duration:00:15:29

Ask host to enable sharing for playback control

Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?

2/27/2024
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Rhonda Cadena, MD, FNCS, FCCM Host: Adrian R. Parry-Jones, FRCP, PhD Host: Stuart Connolly, MD, FRCPC Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

Duration:00:14:29

Ask host to enable sharing for playback control

Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?

2/27/2024
Host: W. Brian Gibler, MD, FACEP, FACC, FAHA Host: Natalie Kreitzer, MD, MS Host: Adrian R. Parry-Jones, FRCP, PhD Host: Rhonda Cadena, MD, FNCS, FCCM Join experts and explore an exciting new frontier of care for patients on direct oral anticoagulants who present with an intracranial hemorrhage. Three factors can be used to optimize treatment: emerging data on anticoagulation reversal, artificial intelligence utilization, and evidence-based ABC care bundling. Learn how these developments transform clinical practice, deepen institutional expertise, and ultimately improve patient outcomes.

Duration:00:13:59